5 Best Growth Stocks To Invest In For the Next 5 Years

4. Eli Lilly and Company (NYSE:LLY)

P/E Ratio: 130.71

Quarterly Revenue Growth: 28.10%

Number of Hedge Fund Holders: 102

Established in 1876, Eli Lilly and Company (NYSE:LLY) is a prestigious American pharmaceutical firm headquartered in Indianapolis, Indiana. Named after its founder, Colonel Eli Lilly, a distinguished pharmaceutical chemist and Civil War veteran, the company boasts a global presence, with operations spanning 18 other countries.

Eli Lilly and Company (NYSE:LLY) attracted attention on April 2 when Citi analyst Andrew Baum raised its shares’ price target to $895 from $675, maintaining a Buy rating.

Insider Monkey’s analysis of hedge fund activity in December 2023 revealed that out of the 933 profiled hedge funds, 102 held shares of the company. Among these, Ken Fisher’s Fisher Asset Management had the largest stake in Eli Lilly and Company (NYSE:LLY), valued at $2.6 billion.